Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CRMD | CorMedix Inc. | Stewart Robert A | Director | May 17, 2023 | Buy | $4.37 | 10,000 | 43,735 | 11,000 | May 18, 2023, 04:51 PM | |
CRMD | CorMedix Inc. | Stewart Robert A | Director | May 17, 2023 | Option Exercise | $4.37 | 10,000 | 43,735 | 11,000 | May 17, 2023, 05:37 PM | |
AMRX | Amneal Pharmaceuticals, Inc. | Stewart Robert A | President and CEO | May 07, 2019 | Option Exercise | $13.44 | 21,609 | 290,425 | 78,668 | May 09, 2019, 05:43 PM | |
AMRX | Amneal Pharmaceuticals, Inc. | Stewart Robert A | President and CEO | Mar 12, 2019 | Buy | $11.92 | 17,000 | 202,640 | 17,000 | Mar 12, 2019, 04:49 PM | |
AGN | Allergan plc | Stewart Robert A | Chief Operating Officer | Dec 29, 2017 | Option Exercise | $163.58 | 2,149 | 351,533 | 66,650 | Jan 02, 2018, 04:41 PM | |
AGN | Allergan plc | Stewart Robert A | Chief Operating Officer | Apr 03, 2017 | Option Exercise | $237.68 | 7,362 | 1,749,800 | 56,372 | Apr 04, 2017, 04:23 PM | |
AGN | Allergan plc | Stewart Robert A | Chief Operating Officer | Mar 05, 2017 | Option Exercise | $245.63 | 761 | 186,924 | 49,010 | Mar 07, 2017, 04:54 PM | |
AGN | Allergan plc | Stewart Robert A | Chief Operating Officer | Feb 01, 2017 | Option Exercise | $229.32 | 2,369 | 543,259 | 50,569 | Feb 03, 2017, 07:56 PM | |
AGN | Allergan plc | Stewart Robert A | Chief Operating Officer | Feb 01, 2017 | Option Exercise | $229.32 | 798 | 182,997 | 49,771 | Feb 03, 2017, 07:56 PM | |
ACT | Actavis plc | Stewart Robert A | Chief Operating Officer | Mar 05, 2015 | Option Exercise | $295.70 | 1,004 | 296,883 | 48,200 | Mar 09, 2015, 06:05 PM | |
ACT | Actavis plc | Stewart Robert A | Pres-Global Operations | May 09, 2014 | Option Exercise | $197.05 | 3,383 | 666,620 | 44,636 | May 13, 2014, 05:21 PM | |
ACT | Actavis plc | Stewart Robert A | Pres-Global Operations | Dec 09, 2013 | Sale | $166.02 | 8,000 | 1,328,160 | 41,253 | Dec 10, 2013, 04:55 PM | |
ACT | Actavis plc | Stewart Robert A | Pres-Global Operations | Nov 15, 2013 | Sale | $164.44 | 10,000 | 1,644,400 | 49,253 | Nov 19, 2013, 05:35 PM | |
ACT | Actavis plc | Stewart Robert A | Pres-Global Operations | Nov 11, 2013 | Sale | $158.39 | 12,000 | 1,900,680 | 59,252 | Nov 13, 2013, 06:36 PM | |
ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operations | Sep 30, 2013 | Option Exercise | $144.00 | 121,951 | 17,560,944 | 71,252 | Oct 02, 2013, 09:16 PM | |
ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operations | Sep 30, 2013 | Option Exercise | $86.86 | 75,000 | 6,514,500 | 148,891 | Oct 02, 2013, 09:16 PM | |
ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operations | Aug 02, 2013 | Sale | $136.02 | 14,564 | 1,980,995 | 73,891 | Aug 13, 2013, 06:01 PM | |
ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operations | Aug 02, 2013 | Option Exercise | $136.02 | 14,564 | 1,980,995 | 73,891 | Aug 06, 2013, 03:56 PM | |
ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operations | Mar 02, 2013 | Option Exercise | $85.54 | 4,834 | 413,500 | 72,320 | Mar 05, 2013, 07:25 PM | |
WPI | WATSON PHARMACEUTICALS INC | Stewart Robert A | Exec VP,Global Operations | Feb 24, 2012 | Option Exercise | $58.17 | 1,640 | 95,399 | 43,103 | Feb 28, 2012, 12:24 PM | |
WPI | WATSON PHARMACEUTICALS INC | Stewart Robert A | Exec VP,Global Operations | Nov 16, 2011 | Option Exercise | $64.52 | 1,622 | 104,651 | 44,743 | Nov 17, 2011, 04:09 PM |